Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Amgen Inc (AMGN) until August 31, 2026. Amgen Inc reported in an 8-K filed May 19, 2026 that Peter Griffith retired as Executive Vice President and Chief Financial Officer, effective August 31, 2026. The proxy statement of Amgen Inc reports total compensation of $7,806,811 for Peter Griffith in fiscal 2024, including a base salary of $1,133,633. Disclosed compensation is on record for 4 fiscal years. Peter Griffith has spoken on 23 earnings calls across 1 company, most recently for Amgen Inc on April 8, 2026. The companies whose calls Peter Griffith spoke on are classified in the Healthcare sector.
“On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.”
“This reinforces confidence in our six key growth drivers and our ability to grow through losses of exclusivity. Together, they demonstrate the breadth and continue to provide a strong foundation for our non-GAAP operating margin was 48%.”
“Continuing strong rare disease and a paid decline to continued increases in 340B program utilization from denosimab $150 million of in-organization.”
“We are pleased with our strong third quarter performance and remain on track with our 2025 full year goals and long-term objectives. The financial results are shown on Slide 6 and 7 of the slide deck.”
“We're pleased with our strong second quarter performance and remain on track with our 2025 full year goals and long-term objectives. The financial results are shown on Slides 31 and 32 of the slide deck.”
“We're pleased with our strong first quarter performance and are on track with our 2025 full year goals and long-term objectives. The financial results are shown on Slides 29 to 30 of the slide deck.”
Start not stated–2026-08-31
AMGN
Drug Manufacturers - General · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amgen Inc (AMGN) | Executive Vice President and Chief Financial Officer | $1,133,633 | $7,806,811 |
| 2023 | Amgen Inc (AMGN) | Executive Vice President and Chief Financial Officer | $1,083,762 | $7,569,298 |
| 2022 | Amgen Inc (AMGN) | Executive Vice President and Chief Financial Officer | $1,044,492 | $7,073,735 |
| 2020 | Amgen Inc (AMGN) | Executive Vice President, and Chief Financial Officer | $998,864 | $6,565,830 |
